Select Page
Chart of the Day / Trump State of Union Winners and Losers

Trump State of Union Winners and Losers

February 6, 2019

After President Trump’s State of the Union, infrastructure and defense stocks are some of the biggest winners on the day.

Meanwhile, drug stocks took a hit on this key statement.

“This is not an option. This is a necessity. The next major priority for me and for all of us should be to lower the cost of health care and prescription drugs and to protect patients with preexisting conditionsAfter my election in 2018, drug prices experienced their single largest decline in 46 years. “But we must do more. It’s unacceptable that Americans pay more than people in other countries for the exact same drugs made in the exact same place.”

Trump asked for Congress to pass a bill that would help deliver “fairness and price transparency for American patients and require drug companies and insurers to disclose real prices, which he said would foster competition and “bring costs way down,” as noted by Zero Hedge.

Defense Stocks Got a Boost

Trump spoked about the $716 billion set aside for military spending in 2019, in addition to the $700 billion spent in 2018. He also referred to a $100 billion increase in spending from NATO allies, noting the U.S. “will outspend and out-innovate all others by far.”

“Boasting about the current funding for defense spending and taking credit for additional contributions from allies, President Trump set a hawkish tone for continued robust levels of defense spending,” said Ed Mills, public policy analyst at Raymond James.

Infrastructure Stocks are Higher, Too

In his State of the Union, Trump also asked for a bipartisan infrastructure push, urging both parties to help rebuild aging, troubling U.S. infrastructure. “I know that Congress is eager to pass an infrastructure bill, and I am eager to work with you on legislation to deliver new and important infrastructure investment,” he noted.

As we dig into these stories a bit more, we’ll share some our favorite trade ideas.